role
glucos
mannos
trim
matur
sindbi
viru
bhk
cell
investig
use
inhibitor
glycoprotein
oligosaccharid
process
presenc
glucosidas
inhibitor
nmethylldeoxynojirimycin
viral
glycoprotein
equip
oligosaccharid
composit
gic
yield
viru
extracellular
medium
reduc
result
block
proteolyt
cleavag
precursor
viral
envelop
glycoprotein
mannosidas
inhibitor
dmm
also
inhibit
appear
viru
medium
oligosaccharid
viral
glycoprotein
composit
man
e
gicnac
howev
cleav
condit
found
yield
viru
cell
medium
togeth
consid
differ
untreat
dmmtreat
cultur
suggest
presenc
intracellular
viru
particl
dmmtreat
cultur
examin
electron
microscopi
dmmtreat
cultur
found
contain
intracellular
viru
particl
addit
nucleocapsid
found
line
intracellular
membran
observ
taken
togeth
plaqu
test
data
intim
sindbi
viru
preferenti
bud
intern
membran
bhk
cell
treat
dmm
result
confirm
essenti
role
glucos
trim
sindbi
virusbhk
cell
system
suggest
initi
stage
mannos
remov
mayb
import
w
academ
press
inc
sindbi
viru
atogaviru
simpl
rnacontain
viru
consist
nucleocapsid
surround
membran
two
viral
glycoprotein
e
embed
viral
protein
gener
sequenti
proteolyt
cleavag
mrna
translat
product
garoff
et
al
e
et
al
oligosaccharid
structur
glc
man
e
g
gicnac
wherea
presenc
bromoconduritol
datema
et
al
oligosaccharid
composit
glc
man
glenac
glycoprotein
sindbi
viru
contain
two
glycosyl
site
hsieh
et
al
whether
particular
glycosyl
site
carri
complex
highmannos
oligosaccharid
presum
determin
larg
extent
exclus
fold
polypeptid
chain
sinc
access
process
enzym
determin
amount
process
take
place
hsieh
et
al
one
glycosyl
site
carri
exclus
complextyp
oligosaccharid
irrespect
whether
viru
grown
avian
mammalian
cell
hsieh
et
al
complextyp
oligosaccharid
gener
via
trim
pathway
kornfeld
kornfeld
trim
precursor
oligosaccharid
gic
mang
gicnac
complex
highmannos
oligosaccharid
characterist
nlink
glycoprotein
initi
endoplasm
reticulum
remov
three
glucos
residu
glucosidas
ii
introduct
grinna
robbin
burn
touster
mannos
trim
may
also
occur
endoplasm
reticulum
bischoff
kornfeld
subsequ
action
mannosidas
golgi
apparatu
complet
remov
four
mannos
residu
taba
kornfeld
addit
gicnac
gicnac
transferas
harpaz
schachter
subsequ
remov
two
mannos
residu
mannosidas
ii
tulsiani
etal
addit
peripher
gicnac
gal
neuac
residu
specif
glycosyltransferas
result
format
complextyp
oligosaccharid
kornfeld
kornfeld
biolog
signific
trim
pathway
rel
import
highmannos
complex
oligosaccharid
proper
function
glycoprotein
studi
specif
inhibitor
trim
glycosidas
schwarz
datema
sever
inhibitor
trim
glycosidas
avail
protein
glycosyl
presenc
glucosidas
inhibitor
saunier
et
al
nmethylldeoxynojirimycin
romero
et
al
castanospermin
pan
mannojirimycin
dmm
z
inhibit
golgi
mannosidas
fuhrmann
et
al
bischoff
kornfeld
protein
equip
oligosaccharid
composit
man
e
gicnac
z
elbein
et
al
swainsonin
hand
inhibit
golgi
mannosidas
ii
tulsiani
et
lead
format
hybridtyp
structur
sindbi
virusinfect
bhk
cell
glucos
trim
inhibit
bromoconduritol
datema
et
al
castanospermin
schlesing
et
al
cleavag
inhibit
expect
requir
cleavag
viru
format
releas
viru
particl
decreas
inhibitortr
cell
effect
revers
lower
incub
temperatur
schlesing
et
infer
equip
glucosyl
highmannos
oligosaccharid
conform
resist
proteolyt
cleavag
therefor
interest
determin
whether
glucos
trim
alon
suffici
allow
viru
matur
whether
mannos
trim
also
requir
thu
rel
role
glucos
mannos
trim
sindbi
viru
matur
bhk
cell
investig
use
glucosidas
mdn
mannosidas
dmm
inhibitor
viru
tissu
cultur
confluent
monolay
bhk
cell
grown
dulbecco
medium
supplement
fetal
calf
serum
cell
infect
sindbi
viru
strain
multipl
infect
plaqueform
unit
per
cell
infect
cell
maintain
either
earl
medium
dulbecco
medium
contain
mmfructos
instead
glucos
indic
text
label
methionin
perform
dulbecco
medium
lack
methionin
use
label
cell
wash
three
time
icecold
phosphatebuff
salin
either
suspend
chloroformmethanol
vv
extract
lipid
lyse
buffer
compris
mm
trishci
ph
sd
mercaptoethanol
glycerol
sdspage
viru
medium
quantit
plaqu
assay
incorpor
methionin
viru
particl
abbrevi
use
mdn
nmethyl
isol
sucros
densiti
centrifug
schwarz
et
nmethylldeoxynojirimycin
mdn
prepar
methyl
suppli
dr
e
truscheit
bayer
ag
wuppert
frg
romero
et
al
obtain
dr
g
kinast
bayer
ag
mdn
dmm
ad
cultur
medium
final
concentr
mm
respect
swainsonin
dr
p
dorl
murdoch
univers
western
australia
use
final
concentr
ugml
tunicamycin
purchas
calbiochem
frankfurt
main
frg
use
final
concentr
inhibitor
ad
cultur
hr
infect
maintain
throughout
incub
period
mannos
cimmol
clabel
protein
hydrolys
mcimatom
methionin
cimmol
bought
amersham
buchler
braunschweig
frg
pronas
endo
h
jack
bean
amannosidas
type
iii
purchas
serv
heidelberg
frg
seikagachu
kogyo
co
ltd
tokyo
japan
sigma
munich
frg
respect
rat
liver
microsom
aglucosidas
prepar
assay
accord
grinna
robbin
oligosaccharid
standard
label
glucos
mannos
moieti
prepar
describ
previous
datema
schwarz
schwarz
datema
character
chromatographi
column
biogel
resist
suscept
digest
aglucosidas
amannosidas
datema
schwarz
datema
et
al
column
biogel
calibr
elut
describ
previous
datema
et
al
datema
et
al
sdspolyacrylamid
gel
electrophoresi
sdspage
label
viral
glycoprotein
perform
gel
use
laemmli
discontinu
system
schwarz
klenk
extract
lipidlink
oligosaccharid
prepar
glycopeptid
describ
elsewher
datema
etal
schwarz
datema
pronas
digest
amannosidas
digest
carri
describ
earlier
datema
schwarz
electron
microscopi
perform
use
publish
procedur
scholtissek
et
necessari
determin
whether
two
inhibitor
mdn
dmm
specif
trim
inhibitor
sindbi
virusinfect
bhk
cell
chick
embryo
cell
use
hand
dmm
inhibit
format
lipidlink
oligosaccharid
cell
elbein
et
howev
effect
role
glucos
mannos
trim
mannos
hr
postinfect
chase
hr
cell
extract
chloroformmethanol
vv
chloroformmethanolwat
vv
remov
lipidlink
oligosaccharid
lipidfre
residu
digest
pronas
result
glycopeptid
desalt
passag
column
biogel
treat
endo
h
analyz
gel
filtrat
biogel
vo
signifi
void
volum
arrow
indic
elut
posit
gic
man
glcnac
refer
compound
peak
character
follow
digest
aglucosidas
amannosidas
describ
datema
et
follow
gic
man
gicnac
man
glcnac
man
gtcnac
glc
glc
man
glcnac
assembl
gic
man
gicnac
ppdol
observ
bhk
cell
presenc
mm
dmm
higher
concentr
mm
inhibitori
effect
observ
data
shown
structur
oligosaccharid
sindbi
viral
glycoprotein
synthes
presenc
either
mm
mdn
mm
dmm
analyz
label
h
mannos
pronas
digest
endo
h
treatment
gel
filtrat
biogel
fig
seen
inhibitor
block
format
complextyp
oligosaccharid
analysi
oligosaccharid
form
presenc
mdn
show
occurr
glc
man
gicnac
fig
b
wherea
presenc
dmm
fig
c
one
major
oligosaccharid
composit
man
gicnac
detect
therefor
inhibitor
exert
specif
block
trim
pathway
infect
bhk
cell
assess
effect
mdn
dmm
releas
viru
extracellular
medium
infect
determin
plaqu
assay
addit
incorpor
methionin
viru
particl
isol
sucros
densiti
centrifug
measur
inhibitor
significantli
suppress
viru
particl
format
tabl
student
test
p
mdn
p
dmm
contrast
dmm
mannosidas
ii
inhibitorswainsonin
inhibitori
effect
viru
format
check
possibl
toxic
nonspecif
effect
mdn
dmm
bhk
cell
infect
strain
influenza
viru
adapt
growth
cell
treat
mdn
dmm
previou
studi
shown
mdn
romero
et
al
dmm
elbein
et
al
affect
format
influenza
viru
inde
chang
hemagglutin
titer
mdnor
dmmtreat
cultur
respect
untreat
control
observ
data
shown
infect
cell
incub
instead
inhibitori
effect
mdn
yield
viru
reduc
tabl
thu
confirm
block
induc
inhibit
glucos
remov
temperatur
sensit
schlesing
et
al
howev
inhibit
caus
dmm
treatment
tabl
proteolyt
cleavag
late
event
occur
prior
bud
viru
either
golgi
transport
cell
surfac
cell
surfac
necessari
viru
particl
product
garoff
et
al
previou
studi
datema
etal
schlesingeret
shown
sindbi
virusinfect
bhk
cell
treat
glucosidas
inhibitor
bromoconduritol
cleavag
block
result
reduct
yield
viru
investig
proteolysi
block
cell
treat
trim
inhibitor
present
studi
treat
cell
label
amino
acid
hr
hr
postinfect
cell
lysat
analyz
sdspage
fig
untreat
cultur
show
format
el
glycoprotein
capsid
protein
c
fig
lane
presenc
mm
mdn
appear
present
fig
lane
indic
cleavag
impair
cell
presenc
mm
dmm
block
evid
fig
lane
protein
synthes
presenc
dmm
migrat
close
togeth
sdspage
due
alter
oligosaccharid
sidechain
glycoprotein
induc
mannosidas
inhibitor
normal
condit
viru
produc
bhk
cell
el
protein
contain
two
complex
oligosaccharid
wherea
protein
contain
one
complex
oligosaccharid
one
highmannos
oligosaccharid
hsieh
et
al
presenc
dmm
protein
glycosyl
exclus
highmannos
oligosaccharid
man
gicnac
z
shown
fig
expect
chang
molecular
weight
el
due
convers
two
complex
oligosaccharid
two
highmannos
oligosaccharid
would
greater
one
complex
oligosaccharid
convert
cultur
treat
mannosidas
ii
inhibitor
swainsonin
also
show
ngml
sw
lane
label
clabel
protein
hydrolys
hr
hr
postintect
lysat
prepar
see
materi
method
protein
separ
sdspage
gel
schwarz
klenk
effect
cleavag
fig
lane
suspect
impair
cleavag
mdntreat
cultur
investig
pulsechas
label
methionin
absenc
presenc
trim
inhibitor
fig
thu
untreat
cultur
treat
dmm
sw
precursor
form
puls
absent
chase
unlabel
medium
min
fig
lane
howev
mdntreat
cultur
fig
lane
still
present
chase
thu
presenc
cell
one
set
plate
harvest
prepar
sdspage
p
set
medium
remov
cell
wash
three
time
warm
phosphatebuff
salin
fresh
medium
contain
appropri
inhibitor
mm
unlabel
methionin
ad
cell
incub
min
harvest
sdspage
c
lane
refer
lysat
cultur
treat
follow
untreat
treat
tim
mdn
treat
mm
dmm
treat
mgml
swk
p
puls
c
chase
mdn
proteolyt
cleavag
impair
like
glucosidas
inhibitor
result
format
viru
inhibit
dmm
howev
affect
cleavag
therefor
inhibit
viru
releas
observ
presenc
dmm
must
due
anoth
caus
similar
experi
sindbisinfect
cell
label
h
palmit
acid
investig
whether
acyl
viral
glycoprotein
affect
trim
inhibitor
effect
acyl
observ
sinc
sindbi
viral
glycoprotein
label
data
shown
intracellular
bud
sindbi
viru
presenc
dmm
one
possibl
caus
reduct
viru
releas
extracellular
medium
dmmtreat
cultur
viru
bud
intracellularli
phenomenon
occur
presenc
monensin
johnson
schlesing
major
rout
sindbi
viru
product
insect
cell
gliedman
et
al
order
test
possibl
yield
infecti
viru
medium
alon
medium
plu
cell
taken
togeth
freez
thaw
three
time
releas
intracellular
viru
particl
determin
tabl
comparison
viru
titer
untreat
dmmtreat
cultur
show
medium
consid
yield
viru
dmmtreat
cultur
significantli
lower
control
student
test
p
howev
signific
differ
untreat
dmmtreat
cultur
yield
viru
medium
plu
cell
consid
student
test
p
tu
sindbi
virusinfect
bhk
cell
treat
inhibitor
hr
postinfect
indic
hr
incub
viru
either
medium
alon
medium
cell
togeth
freez
thaw
three
time
determin
plaqu
assay
lower
titer
medium
cell
control
probabl
consequ
sensit
viru
freez
thaw
treatment
nicamycin
inhibit
protein
glycosyl
block
assembl
lipidlink
oligosaccharid
precursor
schwarz
datema
show
effect
tabl
signific
freezethaw
treatment
dmmtreat
cultur
result
increas
viru
titer
result
suggest
presenc
intracellular
viru
particl
cultur
treat
dmm
howev
similar
result
would
obtain
viru
adher
cell
surfac
therefor
distinguish
two
possibl
electron
microscopi
untreat
dmmtreat
sindbi
virusinfect
bhk
cell
perform
fig
untreat
cell
viru
seen
bud
cell
surfac
fig
wherea
dmmtreat
cell
intracellular
viru
particl
seen
fig
addit
nucleocapsid
found
line
intracellular
membran
fig
provid
evid
viru
assembl
actual
take
place
intracellular
site
find
coupl
plaqu
assay
intim
presenc
dmm
sindbi
viru
bud
preferenti
intracellular
membran
previous
observ
datema
et
al
schlesing
et
al
glucos
trim
essenti
effect
matur
sindbi
viru
infect
bhk
cell
least
one
critic
step
imped
glucos
trim
occur
proteolyt
cleavag
cleavag
previous
shown
requir
viru
releas
review
garoff
et
al
postul
equip
glucosyl
highmannos
oligosaccharid
go
conform
rearrang
make
protein
suscept
cleavag
schlesing
et
al
question
remain
trim
pathway
conform
chang
take
place
shown
glucos
trim
allow
occur
mannos
remov
prevent
inhibit
golgi
mannosidas
cleav
exampl
essenti
role
glucos
trim
glycoprotein
biosynthesi
allow
glucos
trim
prevent
subsequ
mannos
trim
restor
yield
infecti
viru
control
level
although
viru
dmmtreat
cultur
appear
bud
intracellular
membran
greater
extent
viru
untreat
cultur
demonstr
decreas
yield
cellfre
viru
electron
microscopi
find
support
propos
rot
et
al
intracellular
membran
repres
site
second
choic
format
envelop
virus
demonstr
influenza
viru
rott
et
al
stitz
et
rc
electron
microscopi
untreat
sindbi
virusinfect
bhk
cell
virusinfect
cell
either
untreat
treat
bd
mm
dmm
hr
postinfect
incub
hr
harvest
prepar
electron
microscopi
scholtissek
et
af
bd
viru
particl
arrow
insid
dmmtreat
sindbi
virusinfect
bhk
cell
hr
b
hr
c
postinfect
viral
nucleocapsid
n
seen
line
intern
membran
effect
reminisc
observ
monensintr
cell
johnson
schlesing
viru
particl
bud
cell
surfac
untreat
cultur
bar
repres
thatt
small
alter
carbohydr
structur
sindbi
viral
glycoprotein
brought
inhibitor
oligosaccharid
process
lead
choic
second
site
oligosaccharid
composit
glycoprotein
viru
bud
intracellular
membran
untreat
cultur
known
possibl
viru
contain
higher
proport
glycoprotein
less
process
oligosaccharid
viru
releas
bud
plasma
membran
phenomenon
intracellular
bud
viru
observ
cultur
treat
ionophor
monensin
johnson
schlesing
block
intracellular
transport
ci
tran
compart
golgi
apparatu
tartakoff
interest
mannos
trim
block
later
pathway
inhibit
action
golgi
mannosidas
ii
swainsonin
tabl
grow
viru
mutant
cell
lack
gicnac
transferas
schlesingeret
effect
viru
matur
observ
thu
would
appear
initi
stage
mannos
trim
may
import
determin
final
destin
sindbi
viral
glycoprotein
infect
bhk
cell
appar
observ
preferenti
intracellular
bud
prevent
mannos
trim
may
analog
result
sindbi
virusinfect
mosquito
cell
viru
bud
intern
membran
gliedman
et
al
mosquito
cell
lack
termin
glycosyltransferas
necessari
format
complextyp
oligosaccharid
butter
hugh
butter
et
al
glycoprotein
equip
oligosaccharid
composit
man
gicnac
glycosyl
site
would
carri
exclus
complex
oligosaccharid
avian
mammalian
cell
hsieh
robbin
remain
glycosyl
site
carri
highmannos
oligosaccharid
contain
five
nine
mannos
residu
hsieh
robbin
essenti
role
glucos
trim
sindbi
viru
format
observ
studi
correspond
observ
made
vesicular
stomat
viru
schlesing
et
al
mous
hepat
viru
repp
et
consensu
suggest
remov
glucos
residu
essenti
establish
function
conform
viral
glycoprotein
thu
format
influenza
virus
romero
et
elbein
et
al
rou
sarcoma
viru
bosch
bosch
et
affect
either
glucosidas
mannosidas
inhibitor
except
influenza
viru
fowl
plagu
viru
h
n
cleavabl
hemagglutinin
bosch
et
equip
gic
man
gicnac
oligosaccharid
hemagglutinin
metabol
unstabl
datema
et
al
datema
et
al
stabl
oligosaccharid
composit
glc
nlan
glcnac
romero
et
al
clearli
biolog
role
trim
predict
system
must
examin
right
thank
kirstin
schallner
ulrik
klein
technic
assist
dr
c
b
boschek
sabin
grolz
help
electron
microscopi
dr
r
rott
c
scholtissek
interest
encourag
addit
dr
e
truscheit
g
kinast
p
dorl
thank
gift
n
swainsonin
respect
work
support
deutsch
forschungsgemeinschaft
sonderforschungsbereich
fond
der
chemischen
industri
part
work
